In all critical stages in the drug life cycle, BaiPharm can provide specific
recommendations and actionable solutions to clients.
WEBINARS
MORE >
Investigational New Drug (IND) Preparation for U.S. FDA Submission
[ Thursday, 26th September 2024 ]
Understanding Regulatory Requirements for Exporting Drugs to Cambodia, Laos, and Myanmar
[ Wednesday, 13th December 2023 ]
Understanding Regulatory Requirements for Exporting Drugs to Indonesia and Vietnam
[ Thursday, 30th November 2023 ]
LATEST NEWS
POLICY
China Launches the 10th Round of Volume-Based Drug Procurement (VBP)
On November 22, 2024, the China National Joint Drug Procurement Office launched the 10th round of volume-based procurement (VBP), involving 62 drugs. Eligible suppliers must provide basic information by 12:00 PM on December 2 and submit their application dossiers by 10:00 AM on December 12.
Nov 27, 2024
REGULATION
China Standardizes Requirements for Domestic Responsible Persons Designated by Overseas MAHs
On November 14, 2024, China's National Medical Products Administration (NMPA) issued the Interim Provisions on the Management of Designated Domestic Responsible Persons by Overseas Marketing Authorization Holders (MAH) of Drugs.
Nov 19, 2024
REGULATION
Monthly Recap: China Pharmaceutical Regulatory Updates | October 2024
Check out the latest pharma regulatory updates in China: 1. China Releases Several Lists of Reference Listed Drugs (RLDs), 2. China Publishes Re-registration Requirements for Domestically Manufactured Drugs, 3. China Consults on Scope and Procedures for Bioequivalence Test Filings of Chemical Drugs, 4. China CDE Releases Dossier Requirements for the Transfer of Imported Preventive Biological Products to Domestic Production...
Nov 13, 2024